Gut Repair Stack

The Gut Repair Stack targets the gastrointestinal system specifically, combining BPC-157''s mucosal healing properties with KPV''s potent anti-inflammatory action in the gut lining. This combination has become a go-to protocol for functional medicine practitioners working with IBS, Crohn''s disease, ulcerative colitis, SIBO, post-antibiotic gut damage, and leaky gut syndrome. BPC-157 was originally isolated from human gastric juice and was first studied for its effects on the gastrointestinal system. It promotes healing of the gut mucosa through multiple mechanisms: stimulating cell migration to damaged mucosal surfaces, increasing blood flow to the GI tract, and upregulating growth factor expression in intestinal tissue. Both oral and subcutaneous administration are used — oral BPC-157 is increasingly studied for direct GI application. KPV (Lys-Pro-Val) is a tripeptide fragment of alpha-MSH with direct anti-inflammatory effects in the gut. It targets NF-κB signaling, one of the primary inflammatory pathways driving IBD, Crohn''s, and colitis. Unlike systemic anti-inflammatory drugs, KPV acts preferentially in mucosal tissue and can cross the intestinal epithelium to reach submucosal immune cells. It also demonstrates antimicrobial properties that may support a healthier gut microbiome. Together, BPC-157 rebuilds the gut architecture while KPV quiets the immune over-activation that prevents healing. This is particularly powerful in chronic inflammatory gut conditions where the inflammatory environment actively disrupts mucosal repair. Users typically take KPV orally (capsule or liquid) and BPC-157 orally or subcutaneously depending on the condition being targeted.